Liquid chromatography–tandem mass spectrometry (LC–MS/MS) reveals distinct sphingolipid patterns in anorexia and obesity.
|Articles|June 17, 2011
- The Column-06-17-2011
- Volume 7
- Issue 11
The Best Troubleshooting Service in the World... Probably
Incognito gives his ideals on what the ultimate troubleshooting service would look like.
Advertisement
Incognito gives his ideals on what the ultimate troubleshooting service would look like. He asks where people currently tend to go for such advice and how we can learn from other professions and create a comprehensive package that addresses the broadest range of separation problems.
Articles in this issue
over 15 years ago
Iced teaover 15 years ago
Pioneers of the new frontierover 15 years ago
Drug testing compendiumover 15 years ago
Tackling fish fraudover 15 years ago
Market Profile: Flash Chromatographyover 15 years ago
Metal Coatings Analysis by Hand-Held FTIRAdvertisement
Related to this article
Leon Niezen and Gert Desmet discuss uncertainty-driven LC method development, peak overlap, and moving from in silico to real data.
Leon Niezen and Gert Desmet describe how predictive uncertainty can make automated LC method development more reliable.
Liquid chromatography–mass spectrometry (LC–MS) serum profiling ties lysine compounds to lupus kidney disease.
Liquid chromatography-mass spectrometry (LC–MS) growth lifts Waters Q3; MOBILion ion mobility buy expands proteomics.
Liquid chromatography–tandem mass spectrometry (LC–MS/MS) measures galactose-1-phosphate in dried blood spots to monitor galactosemia.
Sam Whitmarsh explores how retention-time models handle interlaboratory data, novel chemotypes, unusual phases and ionisable compounds, and what labs need to do to build useful in-house models.
Advertisement
Advertisement
Trending on LCGC International
1
AI/ML Now: Toxicity Prediction for Unknown LC–HRMS Features Using Machine Learning
2
LCGC Blog: Building a Career Series That Goes Beyond the Surface
3
Industry Roundup: Waters Posts Strong Third Quarter as LC–MS and Chromatography Consumables Drive Growth, Acquires Ion Mobility Pioneer MOBILion
4
From 9000 Clues to a Clinical Test: Mass Spectrometry-Driven Lipidomics for Early Cancer Detection
5